Use of native type II collagen as part of the multiagent Gibelli Flex Active
- Authors: Potupchik T.1, Evert L.2, Akhmeldinova Y.1
-
Affiliations:
- Krasnoyarsk State Medical University
- Research Institute of Medical Problems of the North, Branch Office, Federal Research Center «Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences»
- Issue: Vol 29, No 12 (2018)
- Pages: 33-36
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/117423
- DOI: https://doi.org/10.29296/25877305-2018-12-08
- ID: 117423
Cite item
Abstract
The paper reviews studies of the active ingredients of biologically active additive (BAA) in the dietary supplement Gibelli Flex Active. The BAA components have anti-inflammatory, chondroprotective, antioxidant, and immunomodulatory effects in the treatment of patients with osteoarthritis and improve their mobility and quality of life. Gibelli Flex Active has a good safety profile and can be recommended to treat locomotor diseases in patients of any age.
Full Text
About the authors
T. Potupchik
Krasnoyarsk State Medical University
Email: potupchik_tatyana@mail.ru
Candidate of Medical Sciences
L. Evert
Research Institute of Medical Problems of the North, Branch Office, Federal Research Center «Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences»MD
Yu. Akhmeldinova
Krasnoyarsk State Medical University
References
- Алексеева Л.И. Остеоартроз - проблема века // Мед. совет. - 2013; 5: 2-3.
- Бадокин В.В. Существуют ли хондропротективные препараты? // РМЖ. -2010; 30: 1848.
- Дыдыкина И.С., Дыдыкина П.С., Алексеева О.Г. Вклад микроэлементов (меди, марганца, цинка, бора) в здоровье кости: вопросы профилактики и лечения остеопении и остеопороза // Эффективная фармакотерапия. - 2013; 38: 42-9.
- Каратеев А.Е., Насонова В.А. Возможности повышения эффективности и безопасности терапии пациентов с поясничной болью // Фарматека. - 2013; 13: 75-7.
- Кцоева Е.Л., Гатагонова Т.М., Кцоева С.А. Комбинированное лечение больных остеоартрозом коленного сустава с использованием витамина С // Кубанский научн. мед. вестн. - 2013; 5 (140): 121-4.
- Насонов Е.Л. Нестероидные противовоспалительные препараты / М., 2010.
- Светлова М.С. Патогенетическое лечение остеоартроза коленных суставов // Современная ревматология. - 2012; 3: 1-5.
- Спиричев В.Б. Витамины, витаминоподобные и минеральные вещества. Справочник / М.: Миклом, 2004.
- Третьяк Л.Н., Герасимов Е.М. Специфика влияния селена на организм человека и животных (применительно к проблеме создания селеносодержащих продуктов питания) // Вестник Оренбургского гос. университета. - 2007; 12 (79): 136-45.
- Хабаров А.А., Будко Е.В., Лушов К.А. и др. Цинк: актуальность и характеристики биодобавок (обзор литературы) // Современные проблемы науки и образования. - 2012; 3: [Электронный ресурс]. Режим доступа http://science-education.ru/ru/article/view?id=6416
- Ausar S., Beltramo D., Castagna L. et al. Treatment of rheumatoid arthritis by oral administration of bovine tracheal type II collagen // Rheumat. Internat. -2001; 20: 138-44.
- Bagchi D., Misner B., Bagchi M. et al. Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration // Int. J. Clin. Pharmacol. Res. - 2002; 22: 101-10.
- Bakilan F., Armagan O., Ozgen M. et al. Effects of Native Collagen Type II Treatment // Eurasian J. Med. - 2016; 48: 95-101.
- Crowley D., Lau F., Sharma P. et al. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial // Int. J. Med. Sci. - 2009; 6: 312-21.
- Deberg M., Labasse A., Collette J. et al. One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression // Osteoarthritis Cartilage. - 2005; 13: 1059-65.
- Deberg M., Dubuc J., Labasse A. et al. One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement // Ann. Rheum. Dis. - 2008; 67: 168-74.
- Evcik D., Babaoglu Ü. Osteoartrit Etyopatojenezi. Saridogan M. (Editor). TanidanTedaviyeOsteoartrit / Istanbul: Nobel Tip Kitapevleri, 2007; 51-72.
- Jobin C., Bradham C., Russo M. et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity // J. Immunol. - 1999; 163: 3474-83.
- Jurenka J. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research // Altern. Med. Rev. -2009; 14 (2): 141-53.
- Huebner J., Williams J., Deberg M. et al. Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis // Osteoarthritis Cartilage. - 2010; 18: 397-405.
- Kimmatkar N., Thawani V., Hingorani L. et al. Efficacy and tolerability of Boswelliaserrata extract in treatment of osteoarthritis of knee - A randomized double blind placebo controlled trial // Phytomedicine. - 2003; 10: 3-7.
- Kobayashi N., Kostka G., Garbe J. et al. A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization // J. Biol. Chem. - 2007; 282: 11805-16.
- Meulenbelt I., Kloppenburg M., Kroon H. et al. Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study // Ann. Rheum. Dis. - 2006; 65: 360-5.
- Scarpellini M., Lurati A., Vignati G. et al. Biomarkers, type II collagen, glucosamine and chondroitin sulfate in osteoarthritis follow-up: the «Magenta osteoarthritis study» // J. Orthopaed. Traumatol. - 2008; 9: 81-7.
- Sellam J., Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis // Nat. Rev. Rheumatol. - 2010; 6: 625-35.
- Surh Y., Chun K., Cha H. et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NFkappa B activation // Mutat Res. -2001; 480-481: 243268.
- Trentham D., Halpner A., Trentham R. et al. Treatment of rheumatoid arthritis using undenatured type II collagen // Original Internist. - 2002; 9: 12-5.
- Wei W., Zhang L., Xu J. et al. A multicenter, double-blind, randomized, controlled phase III Clinical trial of chicken type II collagen in rheumatoid arthritis // Arthritis Res. Ther. - 2009; 11: 180